Reach 1,100 Drug Metabolism and Pharmacokinetics Research Scientists with International Society for the Study of Xenobiotics

Members include research scientists and early-career investigators working in drug metabolism, pharmacokinetics, toxicology and molecular biology, who are employed in academic labs, pharmaceutical and biotech companies, and regulatory or research institutes around the world. The International Society for the Study of Xenobiotics (ISSX), founded in 1981, represents over 1,100 scientists and professionals in drug metabolism, pharmacokinetics, and related biomedical fields across more than 40 countries. ISSX offers advertisers a unique opportunity to reach a highly specialized, research-driven audience within the pharmaceutical, biotechnology, and regulatory sectors. Its members are influential in scientific innovation and purchasing decisions, making the society a powerful channel for targeted, high-impact engagement.